UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling Journal article
Gong, Shaolin, Sui, Yuan, Xiao, Mengxuan, Fu, Daoyao, Xiong, Zhiping, Zhang, Liuping, Tian, Qingshan, Fu, Yongnan, Xiong, Wenjun. Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling[J]. Journal of Cardiovascular Pharmacology, 2024, 84(5), 496-505.
Authors:  Gong, Shaolin;  Sui, Yuan;  Xiao, Mengxuan;  Fu, Daoyao;  Xiong, Zhiping; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:2.6/2.5 | Submit date:2024/09/03
Canagliflozin  Cardiac Remodeling  Cardioprotective  Mitophagy  Sglt-2 Inhibitor  
Exploiting Blue Sideband Excitation To Enhance Mode Localization In A Resonant Double-Ended Tuning Fork Magnetometer Conference paper
Wang, Yuan, Zhao, Chun, Xi, Jingqian, Liu, Huafeng, Wang, Chen, Wang, Linlin, Zhang, Shaolin, Wang, Qiu, Hu, Fangjing, Kraft, Michael. Exploiting Blue Sideband Excitation To Enhance Mode Localization In A Resonant Double-Ended Tuning Fork Magnetometer[C], 2023, 525-528.
Authors:  Wang, Yuan;  Zhao, Chun;  Xi, Jingqian;  Liu, Huafeng;  Wang, Chen; et al.
Favorite | TC[Scopus]:0 | Submit date:2024/06/28
Blue-sideband Excitation  Double-ended Tuning Fork  Magnetometer  Mode Localization  
Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents Journal article
Wu Pahau, Zhou Yan, Guo Yizhen, Shaolin Zhang, TAM KIN YIP. Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents[J]. Drug Discovery Today, 2021, 26(3), 836-844.
Authors:  Wu Pahau;  Zhou Yan;  Guo Yizhen;  Shaolin Zhang;  TAM KIN YIP
Adobe PDF | Favorite | TC[WOS]:14 TC[Scopus]:13  IF:6.5/7.3 | Submit date:2024/08/29
Antineoplastic Agents  Drug Design  Drug Development  Glucose/metabolism  Glycolysis  Humans Monocarboxylic Acid Transporters  
Astemizole inhibits mTOR signaling and angiogenesis by blocking cholesterol trafficking Journal article
Lyu,Junfang, Yang,Eun Ju, Head,Sarah A., Ai,Nana, Zhang,Baoyuan, Wu,Changjie, Li,Ruo Jing, Liu,Yifan, Chakravarty,Harapriya, Zhang,Shaolin, Tam,Kin Yip, Dang,Yongjun, Kwon,Ho Jeong, Ge,Wei, Liu,Jun O., Shim,Joong Sup. Astemizole inhibits mTOR signaling and angiogenesis by blocking cholesterol trafficking[J]. International Journal of Biological Sciences, 2018, 14(10), 1175-1185.
Authors:  Lyu,Junfang;  Yang,Eun Ju;  Head,Sarah A.;  Ai,Nana;  Zhang,Baoyuan; et al.
Favorite | TC[WOS]:21 TC[Scopus]:22  IF:8.2/8.3 | Submit date:2021/03/02
Angiogenesis  Astemizole  Cholesterol Trafficking  Mtor  Npc1  
Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking Journal article
Lyu, Junfang, Yang, Eun Ju, Head, Sarah A., Ai, Nana, Zhang, Baoyuan, Wu, Changjie, Li, Ruo-Jing, Liu, Yifan, Chakravarty, Harapriya, Zhang, Shaolin, Tam, Kin Yip, Dang, Yongjun, Kwon, Ho Jeong, Gel, Wei, Liu, Jun O., Shim, Joong Sup. Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14(10), 1175-1185.
Authors:  Lyu, Junfang;  Yang, Eun Ju;  Head, Sarah A.;  Ai, Nana;  Zhang, Baoyuan; et al.
Favorite | TC[WOS]:21 TC[Scopus]:22  IF:8.2/8.3 | Submit date:2018/10/30
Cholesterol Trafficking  Angiogenesis  Astemizole  Npc1  Mtor  
Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells Journal article
Yang, Zheng, Hu, Xiaohui, Zhang, Shaolin, Zhang, Wen, Tam, Kin Yip. Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 815, 80-87.
Authors:  Yang, Zheng;  Hu, Xiaohui;  Zhang, Shaolin;  Zhang, Wen;  Tam, Kin Yip
Favorite | TC[WOS]:14 TC[Scopus]:14  IF:4.2/4.3 | Submit date:2018/10/30
Synergism  Dichloroacetophenone  Dichloroacetate  Egfr  Apoptosis  Acquired Resistance